The potential for novel anti-inflammatory therapies for coronary artery disease

MA Cascieri - Nature Reviews Drug Discovery, 2002 - nature.com
Although drugs that lead to cholesterol and lipid lowering have proved to have significant
effects in lowering cardiovascular morbidity and mortality, coronary artery disease remains a …

High-density Lipoprotein Inhibits Human M1 Macrophage Polarisation through the Redistribution of Caveolin-1

MK Lee, XL Moore, Y Fu, A Al-sharea… - … and Vascular Biology, 2015 - Am Heart Assoc
Macrophages play a critical role in the development and progression of atherosclerosis.
Depending on their surrounding milieu, macrophages can adopt a wide range of functional …

[HTML][HTML] Interleukin-10 overexpression in macrophages suppresses atherosclerosis in hyperlipidemic mice

X Han, S Kitamoto, H Wang, WA Boisvert - The FASEB Journal, 2010 - ncbi.nlm.nih.gov
In atherogenesis, macrophage foam cell formation is modulated by pathways involving both
the uptake and efflux of cholesterol. We recently showed that interleukin-10 (IL-10) …

Atherosclerosis—multiple pathways to lesional macrophages

C Schulz, S Massberg - Science translational medicine, 2014 - science.org
Atherosclerosis is a chronic inflammatory disease that manifests in multiple vascular beds
and frequently culminates in ischemic events, including myocardial infarction. Blood …

Accelerated atherosclerosis in rheumatoid arthritis: mechanisms and treatment

AB Reiss, A Silverman, M Khalfan… - Current …, 2019 - ingentaconnect.com
Background: Rheumatoid arthritis (RA) is a chronic systemic autoimmune inflammatory
disorder that increases the risk of developing cardiovascular disease. There is accumulating …

A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation

JG Lee, EJ Lim, DW Park, SH Lee, JR Kim, SH Baek - Cellular signalling, 2008 - Elsevier
The formation of foam cells is the hallmark of early atherosclerotic lesions, and the uptake of
modified low-density lipoprotein (LDL) by macrophage scavenger receptors is thought to be …

AB0455 Dyslipidemia and Atherogenic Risk in Patients with Systemic Lupus Erythematosus

HA Radillo, JA Batún, E Hernández - 2016 - ard.bmj.com
Background Dyslipidemia is a common comorbidity in patients with systemic lupus
erythematosus, it is favored by central obesity, nephrotic syndrome, glucocorticoids and …

Toll-like receptor 7 stimulation by imiquimod induces macrophage autophagy and inflammation in atherosclerotic plaques

I De Meyer, W Martinet, DM Schrijvers… - Basic research in …, 2012 - Springer
Atherosclerotic plaques tend to rupture as a consequence of a weakened fibrous cap,
particularly in the shoulder regions where most macrophages reside. Macrophages express …

Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids

X Liu, T Ukai, H Yumoto, M Davey, S Goswami… - Atherosclerosis, 2008 - Elsevier
OBJECTIVE: Toll-like receptors (TLRs), a group of pathogen-associated microbial pattern
recognition receptors, play an important role in innate immune signaling and are …

Anti-inflammatory treatment improves high-density lipoprotein function in rheumatoid arthritis

F O'Neill, M Charakida, E Topham, E McLoughlin… - Heart, 2017 - heart.bmj.com
Objective Patients with rheumatoid arthritis (RA) are at increased cardiovascular risk. Recent
studies suggest that high-density lipoprotein (HDL) may lose its protective vascular …